Well Lead Medical Co Ltd
SSE:603309
Well Lead Medical Co Ltd
SSE:603309
Price:
12.68 CNY
-0.24%
Market Closed
Updated:
May 15, 2024
P/FCFE
Price to FCFE
Price to FCFE
19.3
Current
26.3
Median
22.5
Industry
Lower
than median
Lower
than industry value
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
P/FCFE
=19.3
Market Cap
/
3.7B
FCFE
191.6m
All Countries
| Market Cap | P/FCFE | ||||
|---|---|---|---|---|---|
| CN |
|
Well Lead Medical Co Ltd
SSE:603309
|
3.7B CNY | 19.3 | |
| CH |
|
Alcon AG
SIX:ALC
|
39.8B CHF | 136.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.8T JPY | 42.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
188.7B DKK | 68.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.1B USD | 34.7 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.4B USD | 83.3 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | -101.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.5B CNY | 51.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 40.3 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 26.8 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 27 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A
You don't have any saved screeners yet
